Literature DB >> 25832634

TGF-β decreases the stability of IL-18-induced IFN-γ mRNA through the expression of TGF-β-induced tristetraprolin in KG-1 cells.

Yasumichi Inoue1, Kenji Abe, Kikuo Onozaki, Hidetoshi Hayashi.   

Abstract

We have previously reported that transforming growth factor-β (TGF-β) down-regulates interferon-γ (IFN-γ) production in an interleukin-18 (IL-18) treated mouse natural killer (NK) cell line, LNK5E6. In LNK5E6 cells, TGF-β exhibited no inhibition of the IL-18-induced transcription of IFN-γ, but did stimulate the degradation of IFN-γ mRNA induced by IL-18. In the present study, we investigated the mechanism of the down-regulatory effects of TGF-β on IFN-γ mRNA expression in a human myelomonocytic cell line, KG-1, which produces IFN-γ in response to IL-18 alone. Interestingly, IL-18 induced the production of the IFN-γ through the stabilization of IFN-γ mRNA, but not the enhanced transcription of IFN-γ gene. The stability of IFN-γ mRNA was regulated by mRNA destabilizing elements in the 3'untranslated region (UTR) of IFN-γ mRNA, especially adenylate-uridylate (AU)-rich elements (AREs) in the 5' half of 3'UTR. Tristetraprolin (TTP), one of the ARE-binding proteins, destabilizes IFN-γ mRNA, and IL-18 repressed the expression of TTP mRNA. Moreover, TGF-β repressed the IL-18-induced expression of IFN-γ mRNA through the induction of TTP mRNA to destabilize IFN-γ mRNA. Our data is the first to reveal that the crosstalk between IL-18 and TGF-β through the expression of TTP regulates the production of IFN-γ.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25832634     DOI: 10.1248/bpb.b14-00673

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  5 in total

1.  Proteomic analysis reveals distinctive protein profiles involved in CD8+ T cell-mediated murine autoimmune cholangitis.

Authors:  Weici Zhang; Ren Zhang; Jun Zhang; Ying Sun; Patrick Sc Leung; Guo-Xiang Yang; Zongwen Shuai; William M Ridgway; M Eric Gershwin
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

2.  Mycobacterium bovis Wild-Type BCG or Recombinant BCG Secreting Murine IL-18 (rBCG/IL-18) Strains in Driving Immune Responses in Immunocompetent or Immunosuppressed Mice.

Authors:  Marek Fol; Marcin Włodarczyk; Magdalena Kowalewicz-Kulbat; Magdalena Druszczyńska; Krzysztof T Krawczyk; Sebastian Wawrocki; Wiesława Rudnicka; Magdalena Chmiela
Journal:  Vaccines (Basel)       Date:  2022-04-14

3.  TGF-β induces p53/Smads complex formation in the PAI-1 promoter to activate transcription.

Authors:  Yuki Kawarada; Yasumichi Inoue; Fumihiro Kawasaki; Keishi Fukuura; Koichi Sato; Takahito Tanaka; Yuka Itoh; Hidetoshi Hayashi
Journal:  Sci Rep       Date:  2016-10-19       Impact factor: 4.379

4.  Anti-Tumorigenic Activity of Chrysin from Oroxylum indicum via Non-Genotoxic p53 Activation through the ATM-Chk2 Pathway.

Authors:  Mai Nagasaka; Ryoko Hashimoto; Yasumichi Inoue; Kan'ichiro Ishiuchi; Michiyo Matsuno; Yuka Itoh; Muneshige Tokugawa; Nobumichi Ohoka; Daisuke Morishita; Hajime Mizukami; Toshiaki Makino; Hidetoshi Hayashi
Journal:  Molecules       Date:  2018-06-08       Impact factor: 4.411

5.  Construction of Interferon-Gamma-Related Gene Signature to Characterize the Immune-Inflamed Phenotype of Glioblastoma and Predict Prognosis, Efficacy of Immunotherapy and Radiotherapy.

Authors:  Hang Ji; Yixu Ba; Shuai Ma; Kuiyuan Hou; Shan Mi; Xin Gao; Jiaqi Jin; Qin Gong; Ting Liu; Fang Wang; Zhihui Liu; Shupeng Li; Jianyang Du; Shaoshan Hu
Journal:  Front Immunol       Date:  2021-09-10       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.